What is Opko Health's acquisitions?

Opko Health (OPK) reported acquisitions of $0 in Q1 2026.

How has Opko Health's acquisitions changed year-over-year?

Opko Health's acquisitions decreased by 100.0% year-over-year, from $8M to $0.

What does acquisitions mean?

Cash paid for business acquisitions net of cash acquired in the target company — the primary M&A cash flow line.

Opko Health OPK Acquisitions

Acquisitions at other companies

Quest DiagnosticsDGX

$38M—

ImmunomeIMNM

$2.32M—

Bristol-Myers SquibbBMY

$65M-16.7%

Merck & Co.MRK

$8.78B—

AbbVieABBV

$0-100%

Other financials

Income statement

See full

Revenue$124.2M-17.2%

Gross profit$45.8M+7.4%

Operating income-$51.0M+24.0%

Net income-$54.8M+18.9%

EPS (diluted)-$0.07+30.0%

Balance sheet

See full

Cash & equivalents$40.6M-62.5%

Total debt$52.8M-4.2%

Total equity$1.2B-8.2%

Total assets$1.9B-12.8%

Cash flow

See full

Operating cash flow-$19.3M+44.1%

CapEx$1.8M-42.6%

Free cash flow-$21.1M+44.0%

Valuation

See full

Market cap$1.13B+11.5%

P/S1.9×+0.5×

Profitability

See full

Gross margin36%+4.2pp

Operating margin-17.4%-5.6pp

Net margin-36.6%-44.8pp

FCF margin-30%+0.1pp

Returns & leverage

See full

Return on equity-16.9%-21.7pp

Debt / equity0×0.0×

Current ratio3.6×+1.1×

Where this comes from

Reported directly by Opko Health in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates.

The official record: Opko Health’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opko Health's acquisitions.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Opko Health's acquisitions?: Opko Health (OPK) reported acquisitions of $0 in Q1 2026.
How has Opko Health's acquisitions changed year-over-year?: Opko Health's acquisitions decreased by 100.0% year-over-year, from $8M to $0.
What does acquisitions mean?: Cash paid for business acquisitions net of cash acquired in the target company — the primary M&A cash flow line.